Medical specialists from United Kingdom tagged as investigators in clinical trials studying Liver Cirrhosis, Biliary

Total 24 results

David Emrys Jones
Seen in:
- Newcastle Upon Tyne, GSK Investigational Site
- Newcastle upon Tyne, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
David Harman
Seen in:
- Reading, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
David Jones
Seen in:
- Newcastle Upon Tyne, Institute of Cellular Medicine, Newcastle University
- Newcastle, Institute of Cellular Medicine, Newcastle University
Trials:
- NCT04594694 (Principal Investigator)
- NCT05525520 (Principal Investigator)
Conditions:
- Primary Biliary Cholangitis;
- Pruritus
David Sheridan
Seen in:
- Plymouth, GSK Investigational Site
- Plymouth, University Hospitals Plymouth NHS Trust - Derriford Hospital
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05525520 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
Deepak Joshi, MD
Seen in:
- London, King's College Hospital NHS Foundation Trust
Trials:
- NCT05525520 (Principal Investigator)
Conditions:
- Pruritus
Douglas Thorburn
Seen in:
- Hampstead, London, Royal Free Hospital
- London, GSK Investigational Site
- London, Royal Free Hospital, Royal Free London NHS Foundation Trust
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT04663308 (Principal Investigator)
- NCT06286709 (Principal Investigator)
Conditions:
Emma Culver
Seen in:
- Oxford, John Radcliffe Hospital
- Oxford, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust
Trials:
- NCT04594694 (Principal Investigator)
- NCT06286709 (Principal Investigator)
Conditions:
Francisco Perez
Seen in:
- Durham, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
Conditions:
- Pruritus
Gayatri Chakrabarty
Seen in:
- Surrey, Redhill, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
George Mells
Seen in:
- Cambridge, Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital
- Cambridge, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT04663308 (Principal Investigator)
Conditions:
Janisha Patel
Seen in:
- Southampton, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
John Ramage
Seen in:
- Basingstoke, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
Lynsey Corless
Seen in:
- Hull, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
Margaret Corrigan
Seen in:
- Liverpool, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
Conditions:
- Pruritus;
- Cholestasis
Mohamed Saleh
Seen in:
- Kent, Gillingham, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
Conditions:
- Pruritus
Palak Trivedi, MD
Seen in:
- Birmingham, University Hospitals Birmingham NHS Foundation Trust
Trials:
- NCT05525520 (Principal Investigator)
Conditions:
- Pruritus
Simon Rushbrook, MD
Seen in:
- Norwich, Norfolk and Norwich University Hospitals NHS Foundation Trust
Trials:
- NCT05525520 (Principal Investigator)
Conditions:
- Pruritus
Stephen Barclay
Seen in:
- Glasgow, GSK Investigational Site
- Glasgow, Glasgow Royal Infirmary
Trials:
- NCT04167358 (Principal Investigator)
- NCT05525520 (Principal Investigator)
Conditions:
- Cholestasis;
- Pruritus
Stephen Ryder
Seen in:
- Nottingham, GSK Investigational Site
- Nottinghamshire, Nottingham, Queen's Medical Centre, Nottingham University Hospitals
Trials:
- NCT04167358 (Principal Investigator)
- NCT04166773 (Principal Investigator)
- NCT03866187 (Principal Investigator)
Conditions:
Suresh Venkatachalapath, MD
Seen in:
- Nottingham, University of Nottingham - Nottingham Digestive Diseases Centre Biomedical Research Unit
Trials:
- NCT05525520 (Principal Investigator)
Conditions:
- Pruritus
Yiannis Kallis
Seen in:
- London, GSK Investigational Site
Trials:
- NCT04950127 (Principal Investigator)
Conditions:
- Pruritus

Clinical Trials on Liver Cirrhosis, Biliary

University Health Network, Toronto

Unknown

Family Studies in Primary Biliary Cirrhosis (PBC)

Biliary Cirrhosis, Primary

Canada
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis

China
CymaBay Therapeutics, Inc.

Terminated

Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis (PBC)

Germany, United States, Canada, United Kingdom, Poland
University Health Network, Toronto

Unknown

Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)

Liver Cirrhosis, Biliary | Biliary Cirrhosis, Primary

Canada
Xijing Hospital of Digestive Diseases

Unknown

Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis

Primary Biliary Cirrhosis

China
Xijing Hospital of Digestive Diseases

Recruiting

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cirrhosis

China
Christopher Bowlus, MD
Bristol-Myers Squibb

Completed

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis

United States
Dr. Falk Pharma GmbH

Terminated

Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)

Primary Biliary Cirrhosis

France, Germany
University of California, Davis
Genentech, Inc.

Completed

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States
George Brewer
FDA Office of Orphan Products Development

Completed

Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States

Medical specialists from United Kingdom tagged as investigators in clinical trials studying Liver Cirrhosis, Biliary

Clinical Trials on Liver Cirrhosis, Biliary

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations